SomnoMed Limited
SOMNF
$0.4361
-$0.0487-10.05%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -34.40K | -35.40K | -1.94M | -1.94M | -2.07M |
| Total Depreciation and Amortization | 955.50K | 982.50K | 714.30K | 712.80K | 945.90K |
| Total Amortization of Deferred Charges | -- | -- | 571.40K | 570.20K | -- |
| Total Other Non-Cash Items | 407.00K | 418.50K | 430.70K | 429.80K | -368.20K |
| Change in Net Operating Assets | -- | -- | -353.60K | -352.90K | -- |
| Cash from Operations | 1.33M | 1.37M | -579.40K | -578.20K | -1.49M |
| Capital Expenditure | -210.50K | -216.50K | -284.10K | -283.60K | -170.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -240.10K | -246.90K | -748.40K | -746.90K | -548.30K |
| Cash from Investing | -450.60K | -463.40K | -1.03M | -1.03M | -719.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -740.20K | -740.20K | -6.50M | -6.50M | -3.17M |
| Issuance of Common Stock | -- | -- | 11.75M | 11.75M | 7.29M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.20K | -22.20K | -1.04M | -1.04M | -- |
| Cash from Financing | -496.80K | -510.80K | 2.78M | 2.77M | 2.69M |
| Foreign Exchange rate Adjustments | 375.00K | 385.60K | -67.20K | -67.10K | -188.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 755.70K | 777.10K | 1.10M | 1.10M | 287.10K |